West Chester, PA, United States of America

Sally Doreen Patricia Lyn


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sally Doreen Patricia Lyn

Introduction

Sally Doreen Patricia Lyn is a notable inventor based in West Chester, PA (US). She has made significant contributions to the field of biotechnology, particularly in the study of tumor necrosis factor receptors. Her work has implications for understanding and treating various disease states.

Latest Patents

Sally Lyn holds a patent for the invention titled "Human tumor necrosis factor receptor-like 2." This invention relates to novel members of the Tumor Necrosis Factor family of receptors. The patent provides isolated nucleic acid molecules encoding a human TR2 receptor and two splice variants thereof. Additionally, TR2 polypeptides are included, along with vectors, host cells, and recombinant methods for producing these components. The invention also encompasses screening methods for identifying agonists and antagonists of TR2 receptor activity. Furthermore, diagnostic methods for detecting disease states related to the aberrant expression of TR2 receptors are provided. Therapeutic methods for treating disease states associated with the aberrant proliferation and differentiation of cells expressing TR2 receptors are also included.

Career Highlights

Throughout her career, Sally Lyn has worked with prominent companies in the biotechnology sector. She has been associated with Human Genome Sciences, Inc. and SmithKline Beecham Corporation. Her work in these organizations has contributed to advancements in genetic research and therapeutic development.

Collaborations

Sally has collaborated with notable professionals in her field, including Jian Ni and Craig A. Rosen. These collaborations have further enhanced her research and innovation efforts.

Conclusion

Sally Doreen Patricia Lyn is a pioneering inventor whose work on tumor necrosis factor receptors has the potential to impact medical science significantly. Her contributions to biotechnology and her collaborations with esteemed colleagues highlight her importance in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…